Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 20, 2022

SELL
$6.54 - $9.08 $2,328 - $3,232
-356 Reduced 19.91%
1,432 $10,000
Q2 2022

Jul 26, 2022

BUY
$6.82 - $13.82 $2,100 - $4,256
308 Added 20.81%
1,788 $14,000
Q1 2022

May 03, 2022

BUY
$11.65 - $15.28 $5,149 - $6,753
442 Added 42.58%
1,480 $21,000
Q4 2021

Feb 14, 2022

SELL
$12.37 - $16.77 $7,075 - $9,592
-572 Reduced 35.53%
1,038 $15,000
Q3 2021

Nov 16, 2021

BUY
$13.7 - $17.25 $22,057 - $27,772
1,610 New
1,610 $23,000

Others Institutions Holding BVS

About Bioventus Inc.


  • Ticker BVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 61,664,200
  • Market Cap $655M
  • Description
  • Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...
More about BVS
Track This Portfolio

Track Fin Trust Capital Advisors, LLC Portfolio

Follow Fin Trust Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fin Trust Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fin Trust Capital Advisors, LLC with notifications on news.